These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33923564)

  • 1. Clinical Features and Cutaneous Manifestations of Juvenile and Adult Patients of Dermatomyositis Associated with Myositis-Specific Autoantibodies.
    Okiyama N
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33923564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies.
    Okiyama N; Fujimoto M
    F1000Res; 2019; 8():. PubMed ID: 31824645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
    Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
    J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
    Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
    Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatomyositis: Clinical features and pathogenesis.
    DeWane ME; Waldman R; Lu J
    J Am Acad Dermatol; 2020 Feb; 82(2):267-281. PubMed ID: 31279808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.
    Muro Y; Sugiura K; Akiyama M
    Clin Rev Allergy Immunol; 2016 Dec; 51(3):293-302. PubMed ID: 26100618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the classification and assessment of the cutaneous manifestations of the idiopathic inflammatory myopathies.
    Dugan EM; Huber AM; Miller FW; Rider LG;
    Dermatol Online J; 2009 Feb; 15(2):2. PubMed ID: 19336019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Features of Myositis-Associated Autoantibodies: a Review.
    Gunawardena H
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):45-57. PubMed ID: 26453338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and autoantibody phenotypes of juvenile dermatomyositis.
    Boyarchuk O; Kuka A; Yuryk I
    Reumatologia; 2022; 60(4):281-291. PubMed ID: 36186835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on Cutaneous Signs to Assist in the Diagnosis of Dermatomyositis.
    El-Banna G; Fiorentino D
    Curr Rheumatol Rep; 2022 May; 24(5):156-165. PubMed ID: 35404005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Classification of idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific antibodies].
    Zheng S; Chen S; Wu L; Zhao D; Chen F; Zhu J; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):1029-1035. PubMed ID: 32895158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
    Dourmishev LA
    Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New autoantibodies in dermatomyositis].
    Bielsa I
    Actas Dermosifiliogr; 2009 Apr; 100(3):182-9. PubMed ID: 19457303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].
    Gan YZ; Li YH; Zhang LH; Ma L; He WW; Jin YB; An Y; Li ZG; Ye H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1001-1008. PubMed ID: 33331305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of autoantibodies for the diagnosis of autoimmune myopathies].
    Allenbach Y; Benveniste O
    Rev Neurol (Paris); 2013; 169(8-9):656-62. PubMed ID: 23642286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis].
    Váncsa A; Dankó K
    Orv Hetil; 2016 Jul; 157(30):1179-84. PubMed ID: 27452067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myositis-specific autoantibodies].
    Fujimoto M
    Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
    Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
    Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients.
    Betteridge Z; Tansley S; Shaddick G; Chinoy H; Cooper RG; New RP; Lilleker JB; Vencovsky J; Chazarain L; Danko K; Nagy-Vincze M; Bodoki L; Dastmalchi M; Ekholm L; Lundberg IE; McHugh N;
    J Autoimmun; 2019 Jul; 101():48-55. PubMed ID: 30992170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.